Tag: Bureau of Competition

Displaying 121 - 140 of 858 results.

Pages

The Federal Trade Commission staff submitted a supplemental comment and analysis to the Tennessee Department of Health that opposes issuing a certificate of public advantage, or COPA, to Mountain States Health Alliance and Wellmont Health System.
The Federal Trade Commission announced today that it is hosting a workshop in Washington, DC on April 18, 2017, to examine competition, innovation, and consumer protection issues raised by hearing health and technology, particularly hearing aids and devices with similar functions and features.
It was another busy year for antitrust news.  Here’s my look back at the top ten FTC-related antitrust developments for the year that was 2016 (in chronological order):
Before we start making New Year’s resolutions for 2017, let’s assess last year’s pledges. In announcing Operation Collection Protection, a coordinated federal-state-local initiative to take on illegal debt collection practices, we made two promises: 1) to continue our commitment in...
German pharmaceutical company Boehringer Ingelheim has agreed to divest five types of animal health products in the United States in order to settle FTC charges that its proposed asset swap with Paris-based Sanofi would likely be anticompetitive.
U.S.-based global healthcare company Abbott Laboratories has agreed to divest two medical device businesses to settle FTC charges that its proposed $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive.
Federal Trade Commission staff has submitted a comment to the Iowa Board of Physician Assistants supporting a regulatory proposal to define physician supervision of a physician assistant (PA), in response to a Board request for public comments.
Following a public comment period, the Federal Trade Commission has approved an application from American Air Liquide Holdings, Inc. to sell to Reliant Holdings, Ltd. certain assets related to production of bulk liquid carbon dioxide and dry ice at facilities in Galva, and Sergeant Bluff, Iowa.
The Federal Trade Commission has issued its 2016 Report on Ethanol Market Concentration, an annual report required by the Energy Policy Act of 2005 “to determine whether there is sufficient competition among industry participants to avoid price-setting and other anticompetitive behavior.”
Federal Trade Commission staff submitted a comment to the Delaware Board of Speech/Language Pathologists, Audiologists and Hearing Aid Dispensers on its proposed regulation that would allow telepractice in those fields but require an initial in-person evaluation.
When submitting a Hart-Scott-Rodino (HSR) premerger notification filing to the FTC and DOJ, a filing party must complete the HSR Form. The HSR Form requires detailed information about the transaction and the filing party’s business, and requires the submission of certain documents...
The Federal Trade Commission staff submitted a comment to the Tennessee Department of Health that opposes issuing a certificate of public advantage (COPA) to Mountain States Health Alliance and Wellmont Health System. If approved, the COPA could allow the merger of Mountain States and Wellmont, the...
Everyone seems to have a view about the so-called “Sharing Economy.” At our June 2015 workshop, panelists spoke for seven hours.
A Federal Trade Commission staff report released today provides an in-depth assessment of evolving business models that rely on internet and app-based “sharing economy” platforms used by millions of Americans. The report summarizes a June 2015 FTC public workshop and highlights a number of...
Following a public comment period, the Federal Trade Commission has approved an application from HeidelbergCement AG and Italcementi S.p.A. to sell the Essroc cement plant in Martinsburg, West Virginia, eight cement terminals in the mid-Atlantic, and related assets to Argos USA LLC, a subsidiary of...
The Federal Trade Commission filed an amicus brief with the U.S. Court of Appeals for the First Circuit urging the court to reverse the district court’s dismissal of the complaint in Amphastar Pharmaceuticals, Inc. v. Momenta Pharmaceuticals, Inc.
Canadian pharmaceutical conglomerate Valeant Pharmaceuticals International, Inc., parent of Bausch + Lomb, has agreed to divest Paragon Holdings I, Inc. to settle charges that its May 2015 acquisition of Paragon violated Section 7 of the Clayton Act and Section 5 of the Federal Trade Commission Act...
The Federal Trade Commission and the Department of Justice’s Antitrust Division seek public comment on proposed Antitrust Guidelines for International Enforcement and Cooperation, which update guidelines issued by the Agencies in 1995.

Pages